Mirtazapina Normon (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which raises norepinephrine and serotonin release. It also antagonizes postsynaptic 5‑HT2 and 5‑HT3 receptors and has strong H1‑receptor antagonism, collectively enhancing serotonergic activity and producing antidepressant effects.

The specific dose of Mirtazapina Normon is determined by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mirtazapine differs from SSRIs and SNRIs by its dual antagonism of α2‑adrenergic and specific serotonin receptors, which often results in strong sedative and appetite‑stimulating effects. This profile can be advantageous for patients with insomnia or weight loss, but may be less suitable for those concerned about weight gain.

Mirtazapina Normon should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability.

The medication is taken orally, usually once daily in the evening, as directed by the prescriber. It should be swallowed whole with water and not crushed or chewed unless otherwise instructed.

Serious risks include agranulocytosis, severe hyponatremia, hepatotoxicity, and rare cases of suicidal thoughts, especially during early treatment. Patients should be monitored closely for any sudden changes in mood, blood counts, or liver function.

Mirtazapina Normon is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, and in those currently taking monoamine oxidase inhibitors. Caution is also advised for individuals with severe hepatic impairment or uncontrolled medical conditions.